No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Chemotherapy, Adjuvant
-
Female
-
Follow-Up Studies
-
Humans
-
Ipilimumab
-
Melanoma / drug therapy*
-
Melanoma / pathology*
-
Melanoma / surgery
-
Methylprednisolone / therapeutic use
-
Myasthenia Gravis / chemically induced*
-
Myasthenia Gravis / physiopathology
-
Myasthenia Gravis / therapy
-
Plasmapheresis / methods
-
Risk Assessment
-
Sampling Studies
-
Severity of Illness Index
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology*
-
Skin Neoplasms / surgery
-
Survival Rate
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Ipilimumab
-
Methylprednisolone